As part of the Helping to End Addiction Long-termSM Initiative, or the NIH HEAL InitiativeSM, NCATS is applying breakthrough approaches of translational science to advance new treatments for opioid misuse and addiction and for pain. Learn more about NCATS’ role.
-
Research
-
- Funding & Notices
- News & Media
- About Translation
-
- About NCATS
-
NCATS Programs & Initiatives
- 3-D Tissue Bioprinting Program
- Assay Development and Screening Technology (ADST)
- Biomedical Data Translator
- Bridging Interventional Development Gaps (BrIDGs)
- Chemistry Technology
- Discovering New Therapeutic Uses for Existing Molecules
- Genetic and Rare Diseases Information Center (GARD)
- Matrix Combination Screening
- Early Translation Branch (ETB)
- A Specialized Platform for Innovative Research Exploration (ASPIRE)
- About NCATS
NCATS' Role in the NIH HEAL Initiative
Apply: ASPIRE Reduction-to-Practice Challenge Accepting Submissions Starting Nov. 30The NCATS ASPIRE Reduction-to-Practice Challenge is open for submissions. ASPIRE is supported through the NIH Heal InitiativeSM.
About NCATS' Role in the NIH HEAL InitiativeRead more about NCATS’ role in the NIH HEAL Initiative.
Fiscal Year 2019 Funded Projects and PrizesLearn more about the fiscal year 2019 funded prizes and projects.
About NCATS' Role in the NIH HEAL Initiative
Read more about NCATS’ role in the NIH HEAL Initiative.
Fiscal Year 2019 Funded Projects and Prizes
Learn more about the fiscal year 2019 funded prizes and projects.
Contact
- Funding & Notices
-